180 Wealth Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$376K Buy
24,934
+9,171
+58% +$160K 0.04% 341
2026
Q1
$302K Buy
15,763
+2,320
+17% +$50.4K 0.03% 359
2025
Q4
$295K Buy
13,443
+3,047
+29% +$55K 0.03% 373
2025
Q3
$126K Buy
+10,396
New +$141K 0.02% 442
2025
Q1
Sell
-6,776
Closed -$244K 447
2024
Q4
$244K Buy
6,776
+60
+0.9% +$2.03K 0.04% 349
2024
Q3
$285K Sell
6,716
-246
-4% -$10.4K 0.04% 341
2024
Q2
$315K Sell
6,962
-692
-9% -$28.9K 0.05% 305
2024
Q1
$271K Sell
7,654
-383
-5% -$10.3K 0.05% 316
2023
Q4
$228K Buy
+8,037
New +$167K 0.05% 326

Other funds holding TNDM

180 Wealth Advisors's TNDM Position: Q2 2026 in Review

180 Wealth Advisors increased its Tandem Diabetes Care (TNDM) stake by 58% in Q2 2026, buying an estimated $160K and bringing the position to 24,934 shares worth $376K. The position accounts for 0.04% of the portfolio, ranked #341.

180 Wealth Advisors first reported a position in TNDM in Q4 2023 and has held it in 9 quarters since. 22 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • 180 Wealth Advisors held 24,934 shares of Tandem Diabetes Care worth $376K as of Q2 2026.
  • 180 Wealth Advisors bought 9,171 Tandem Diabetes Care shares in Q2 2026, an estimated $160K.
  • Tandem Diabetes Care made up 0.04% of 180 Wealth Advisors's portfolio in Q2 2026, its #341 holding.
  • 180 Wealth Advisors first reported a position in Tandem Diabetes Care in Q4 2023 and has held it in 9 quarters since.
  • 22 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on 180 Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.